A critical relationship of MetS with dyslipidemia involves insulin resistance development in peripheral tissues resulting in an elevated hepatic surge of fatty acids from intravascular lipolysis, dietary sources, as well as adipose tissue that is resistant to the antilipolytic influences of insulin (Klop et al., 2013; Aroor et al., 2019). This evidence concerns the gene INS and metabolic syndrome.